|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jiang X, Wang J, Deng X, Xiong F, Zhang S,
Gong Z, Li X, Cao K, Deng H, He Y, et al: The role of
microenvironment in tumor angiogenesis. J Exp Clin Cancer Res.
39:2042020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Saito T, Tanaka R, Wataba K, Kudo R and
Yamasaki H: Overexpression of estrogen receptor-alpha gene
suppresses gap junctional intercellular communication in
endometrial carcinoma cells. Oncogene. 23:1109–1116. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang JX and Gu S: Gap junction- and
hemichannel-independent actions of connexins. Biochim Biophys Acta.
1711:208–214. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goodenough DA and Paul DL: Gap junctions.
Cold Spring Harb Perspect Biol. 1:a0025762009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nielsen MS, Axelsen LN, Sorgen PL, Verma
V, Delmar M and Holstein-Rathlou NH: Gap junctions. Compr Physiol.
2:1981–2035. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Saez JC, Berthoud VM, Branes MC, Martinez
AD and Beyer EC: Plasma membrane channels formed by connexins:
Their regulation and functions. Physiol Rev. 83:1359–1400. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lampe PD and Lau AF: The effects of
connexin phosphorylation on gap junctional communication. Int J
Biochem Cell Biol. 36:1171–1186. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maeda S and Tsukihara T: Structure of the
gap junction channel and its implications for its biological
functions. Cell Mol Life Sci. 68:1115–1129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roy S, Jiang JX, Li AF and Kim D: Connexin
channel and its role in diabetic retinopathy. Prog Retin Eye Res.
61:35–59. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Söhl G and Willecke K: Gap junctions and
the connexin protein family. Cardiovasc Res. 62:228–232. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Solan JL and Lampe PD: Connexin
phosphorylation as a regulatory event linked to gap junction
channel assembly. Biochim Biophys Acta. 1711:154–163. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meşe G, Richard G and White TW: Gap
junctions: Basic structure and function. J Invest Dermatol.
127:2516–2524. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Laws MJ, Taylor RN, Sidell N, DeMayo FJ,
Lydon JP, Gutstein DE, Bagchi MK and Bagchi IC: Gap junction
communication between uterine stromal cells plays a critical role
in pregnancy-associated neovascularization and embryo survival.
Development. 135:2659–2668. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Buschmann I, Pries A, Styp-Rekowska B,
Hillmeister P, Loufrani L, Henrion D, Shi Y, Duelsner A, Hoefer I,
Gatzke N, et al: Pulsatile shear and Gja5 modulate arterial
identity and remodeling events during flow-driven arteriogenesis.
Development. 137:2187–2196. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Walker DL, Vacha SJ, Kirby ML and Lo CW:
Connexin43 deficiency causes dysregulation of coronary
vasculogenesis. Dev Biol. 284:479–498. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gärtner C, Ziegelhöffer B, Kostelka M,
Stepan H, Mohr FW and Dhein S: Knock-down of endothelial connexins
impairs angiogenesis. Pharmacol Res. 65:347–357. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang HH, Su CH, Wu YJ, Li JY, Tseng YM,
Lin YC, Hsieh CL, Tsai CH and Yeh HI: Reduction of connexin43 in
human endothelial progenitor cells impairs the angiogenic
potential. Angiogenesis. 16:553–560. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chou Y, Tsai CH, Ueng KC, Tian TY, Chen SC
and Yeh HI: Endothelial gap junctions are down-regulated by arsenic
trioxide. Eur J Pharmacol. 569:29–36. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang HH, Kung CI, Tseng YY, Lin YC, Chen
CH, Tsai CH and Yeh HI: Activation of endothelial cells to
pathological status by down-regulation of connexin43. Cardiovasc
Res. 79:509–518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koepple C, Zhou Z, Huber L, Schulte M,
Schmidt K, Gloe T, Kneser U, Schmidt VJ and de Wit C: Expression of
Connexin43 stimulates endothelial angiogenesis independently of Gap
junctional communication in vitro. Int J Mol Sci. 22:74002021.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jansen JA, van Veen TA, de Bakker JM and
van Rijen HV: Cardiac connexins and impulse propagation. J Mol Cell
Cardiol. 48:76–82. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schulz R, Görge PM, Görbe A, Ferdinandy P,
Lampe PD and Leybaert L: Connexin 43 is an emerging therapeutic
target in ischemia/reperfusion injury, cardioprotection and
neuroprotection. Pharmacol Ther. 153:90–106. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Omasits U, Ahrens CH, Müller S and
Wollscheid B: Protter: Interactive protein feature visualization
and integration with experimental proteomic data. Bioinformatics.
30:884–886. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Marsic D, Hughes RC, Byrne-Steele ML and
Ng JD: PCR-based gene synthesis to produce recombinant proteins for
crystallization. BMC Biotechnol. 8:442008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Distler O, Neidhart M, Gay RE and Gay S:
The molecular control of angiogenesis. Int Rev Immunol. 21:33–49.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Polverini PJ: The pathophysiology of
angiogenesis. Crit Rev Oral Biol Med. 6:230–247. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Goel S, Duda DG, Xu L, Munn LL, Boucher Y,
Fukumura D and Jain RK: Normalization of the vasculature for
treatment of cancer and other diseases. Physiol Rev. 91:1071–1121.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bir SC, Xiong Y, Kevil CG and Luo J:
Emerging role of PKA/eNOS pathway in therapeutic angiogenesis for
ischaemic tissue diseases. Cardiovasc Res. 95:7–18. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fernandes R, Girão H and Pereira P: High
glucose down-regulates intercellular communication in retinal
endothelial cells by enhancing degradation of connexin 43 by a
proteasome-dependent mechanism. J Biol Chem. 279:27219–27224. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Palatinus JA, Rhett JM and Gourdie RG: The
connexin43 carboxyl terminus and cardiac gap junction organization.
Biochim Biophys Acta. 1818:1831–1843. 2012. View Article : Google Scholar : PubMed/NCBI
|
